DLVR-M Trademark

Trademark Overview


On Friday, June 7, 2024, a trademark application was filed for DLVR-M with the United States Patent and Trademark Office. The USPTO has given the DLVR-M trademark a serial number of 98589968. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 7, 2024. This trademark is owned by Nvelop Therapeutics, Inc.. The DLVR-M trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

pharmaceutical preparations for gene therapy and gene editing; drug delivery agents that facilitate de livery of pharmaceuticals, namely, drug delivery agents consisting of particles that facilitate delivery of a wide range of pharmaceuticals; drug carriers for medical use, namely, drug delivery agents in the form of engineered particles that facilitate the delivery of pharmaceutical preparations for delivering drugs to human cells, tissues and organs; cell and gene therapy products for increasing protein expression in cells namely, engineered particles; pharmaceutical and biological preparations for delivering agents including proteins, nucleic acids, ribonucleoproteins, and small molecules into cells for the prevention, diagnosis and treatment of genetic diseases, namely, cancer, including hematological and solid tumors, autoimmune diseases, cardiovascular disease, respiratory disease, pulmonary disease, central nervous system diseases and disorders, mitochondrial diseases and disord...

drug delivery agents that facilitate delivery of pharmaceuticals, namely, engineered particles
dlvr-m

General Information


Serial Number98589968
Word MarkDLVR-M
Filing DateFriday, June 7, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, June 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical preparations for gene therapy and gene editing; drug delivery agents that facilitate de livery of pharmaceuticals, namely, drug delivery agents consisting of particles that facilitate delivery of a wide range of pharmaceuticals; drug carriers for medical use, namely, drug delivery agents in the form of engineered particles that facilitate the delivery of pharmaceutical preparations for delivering drugs to human cells, tissues and organs; cell and gene therapy products for increasing protein expression in cells namely, engineered particles; pharmaceutical and biological preparations for delivering agents including proteins, nucleic acids, ribonucleoproteins, and small molecules into cells for the prevention, diagnosis and treatment of genetic diseases, namely, cancer, including hematological and solid tumors, autoimmune diseases, cardiovascular disease, respiratory disease, pulmonary disease, central nervous system diseases and disorders, mitochondrial diseases and disorders, endocrine disorders, gastrointestinal diseases, auditory processing disorders (APD) and hearing loss disorders, inflammatory diseases, acquired and innate immunodeficiencies, kidney disease, liver disease, metabolic diseases and disorders, musculoskeletal disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, brain disorders and diseases, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes; pharmaceutical and biological preparations for delivering therapeutic agents including proteins, nucleic acids, ribonucleoproteins, and small molecules for treatment of cancer, including hematological and solid tumors, autoimmune diseases, cardiovascular disease, respiratory disease, pulmonary disease, central nervous system diseases and disorders, mitochondrial diseases and disorders, endocrine disorders, gastrointestinal diseases, genetic diseases and disorders, auditory processing disorders (APD) and hearing loss disorders, inflammatory diseases, acquired and innate immunodeficiencies, kidney disease, liver disease, metabolic diseases and disorders, musculoskeletal disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, brain disorders and diseases, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes
Goods and Servicesdrug delivery agents that facilitate delivery of pharmaceuticals, namely, engineered particles

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, June 7, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNvelop Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02199

Trademark Events


Event DateEvent Description
Friday, June 7, 2024NEW APPLICATION ENTERED